Showing results (1-10 of 104) with videos related to
Sort By:
Pageof 11
Current Oncology Reports|January 19, 2016
Radionuclide Therapies in Prostate Cancer: Integrating Radium-223 in the Treatment of Patients With Metastatic Castration-Resistant Prostate CancerSten NilssonExpert Opinion on Drug Safety|May 30, 2015
Radium-223 dichloride for the treatment of bone metastatic castration-resistant prostate cancer: an evaluation of its safetySten NilssonAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Alpha-emitter radium-223 in the management of solid tumors: current status and future directionsSten NilssonSeminars in Nuclear Medicine|November 10, 2016
Radium-223 Therapy of Bone Metastases in Prostate CancerSten NilssonUrology|April 15, 2008
Testosterone surge: rationale for gonadotropin-releasing hormone blockers?Hendrik van Poppel, Sten NilssonActa Oncologica (Stockholm, Sweden)|May 25, 2011
Hypofractionation for radiotherapy of prostate cancer using a low alfa/beta ratio--possible reasons for concerns? An example of five dimensional radiotherapyBo Lennernäs, Sten Nilsson, Seymour LevittEuropean Journal of Cancer (Oxford, England : 1990)|May 3, 2005
Intention to test for prostate cancerGunilla Berglund, Sten Nilsson, Karin NordinActa Oncologica (Stockholm, Sweden)|August 12, 2004
A systematic overview of radiation therapy effects in prostate cancerSten Nilsson, Bo Johan Norlén, Anders WidmarkOncology Reports|October 5, 2007
Calculated and simulated effects of heterogeneous dose distributions in radiotherapy using the dose volume inhomogeneity corrected biological equivalent dose formula with special reference to prostate cancerBo Lennernäs, Per Albertsson, Maliha Edgren, et al.Cancer Nursing|June 1, 2002
Self-perceived physical, psychologic, and general symptoms in survivors of testicular cancer 3 to 13 years after treatmentLennart Rudberg, Marianne Carlsson, Sten Nilsson, et al.Pageof 11